FDA Inspection 1043275 — AGC Biologics A/S
The FDA completed an inspection of AGC Biologics A/S on November 7, 2017 in Soborg. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 7, 2017
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Soborg (Denmark)